3U9Q image
Entry Detail
PDB ID:
3U9Q
Keywords:
Title:
Ligand binding domain of PPARgamma complexed with Decanoic Acid and PGC-1a peptide
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2011-10-19
Release Date:
2011-11-09
Method Details:
Experimental Method:
Resolution:
1.52 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Peroxisome proliferator-activated receptor gamma
Chain IDs:A
Chain Length:269
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:PGC-1a peptide
Chain IDs:B
Chain Length:9
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Identification and Mechanism of 10-Carbon Fatty Acid as Modulating Ligand of Peroxisome Proliferator-activated Receptors.
J.Biol.Chem. 287 183 195 (2012)
PMID: 22039047 DOI: 10.1074/jbc.M111.294785

Abstact

Peroxisome proliferator-activated receptors (PPARα, -β/δ, and -γ) are a subfamily of nuclear receptors that plays key roles in glucose and lipid metabolism. PPARγ is the molecular target of the thiazolidinedione class of antidiabetic drugs that has many side effects. PPARγ is also activated by long chain unsaturated or oxidized/nitrated fatty acids, but its relationship with the medium chain fatty acids remains unclear even though the medium chain triglyceride oils have been used to control weight gain and glycemic index. Here, we show that decanoic acid (DA), a 10-carbon fatty acid and a major component of medium chain triglyceride oils, is a direct ligand of PPARγ. DA binds and partially activates PPARγ without leading to adipogenesis. Crystal structure reveals that DA occupies a novel binding site and only partially stabilizes the AF-2 helix. DA also binds weakly to PPARα and PPARβ/δ. Treatments with DA and its triglyceride form improve glucose sensitivity and lipid profiles without weight gain in diabetic mice. Together, these results suggest that DA is a modulating ligand for PPARs, and the structure can aid in designing better and safer PPARγ-based drugs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures